Concepedia

Xingdong Zhao

XZ

3

Publications

41

Citations

3

H-Index

2020

Active since

Affiliations

Shanghai Institute of Materia Medica(Current)

Fosun Pharma (China)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Xingdong Zhao is an author at Shanghai Institute of Materia Medica specializing in oncology, medicine, and tumor biology.

Top concepts

Publications per year

2020–2021

3

Publications

3

SAF-189s, a potent new-generation ROS1 inhibitor, is active against crizotinib-resistant ROS1 mutant-driven tumors

Zongjun Xia, Yinchun Ji, Deqiao Sun et al. · Acta Pharmacologica Sinica · 2020 · 16 citations · Full text

, , +7

Abstract 1951: FCN-159: A novel, potent and selective oral inhibitor of MEK1/2 for the treatment of solid tumors

Shu Yu Lin, Xingdong Zhao, Zuwen Zhou et al. · Cancer Research · 2020 · 14 citations

, , +18

SAF-248, a novel PI3Kδ-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma

Xi Zhang, Yuting Duan, Yi Wang et al. · Acta Pharmacologica Sinica · 2021 · 11 citations · Full text

, , +9

Rows per page

1–3 of 3